3-7497905-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.1515+36183T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.487 in 151,926 control chromosomes in the GnomAD database, including 18,424 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 18424 hom., cov: 32)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.654

Publications

2 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.1515+36183T>C
intron
N/ANP_000835.1Q14831-1
GRM7
NM_181874.3
c.1515+36183T>C
intron
N/ANP_870989.1Q14831-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.1515+36183T>C
intron
N/AENSP00000350348.4Q14831-1
GRM7
ENST00000389336.8
TSL:1
c.1515+36183T>C
intron
N/AENSP00000373987.4Q14831-5
GRM7
ENST00000389335.7
TSL:1
n.1515+36183T>C
intron
N/AENSP00000373986.3Q14831-4

Frequencies

GnomAD3 genomes
AF:
0.487
AC:
73906
AN:
151808
Hom.:
18404
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.503
Gnomad AMI
AF:
0.343
Gnomad AMR
AF:
0.497
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.718
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.545
Gnomad MID
AF:
0.465
Gnomad NFE
AF:
0.453
Gnomad OTH
AF:
0.480
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.487
AC:
73975
AN:
151926
Hom.:
18424
Cov.:
32
AF XY:
0.494
AC XY:
36698
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.503
AC:
20850
AN:
41442
American (AMR)
AF:
0.498
AC:
7597
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
1455
AN:
3472
East Asian (EAS)
AF:
0.717
AC:
3699
AN:
5156
South Asian (SAS)
AF:
0.493
AC:
2374
AN:
4812
European-Finnish (FIN)
AF:
0.545
AC:
5746
AN:
10534
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.453
AC:
30792
AN:
67928
Other (OTH)
AF:
0.480
AC:
1013
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1917
3833
5750
7666
9583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
668
1336
2004
2672
3340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.458
Hom.:
8445
Bravo
AF:
0.483
Asia WGS
AF:
0.585
AC:
2025
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.7
DANN
Benign
0.51
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6764561; hg19: chr3-7539592; API